Literature DB >> 7472584

Decreased uptake of iodinated branched fatty acid analog indicates metabolic alterations in ischemic myocardium.

N Tamaki1, E Tadamura, M Kawamoto, Y Magata, Y Yonekura, Y Fujibayashi, R Nohara, S Sasayama, J Konishi.   

Abstract

UNLABELLED: We previously reported that uptake of 123I-labeled 15-iodophenyl 3-methyl pentadecanoic acid (BMIPP) was lower than that of thallium in ischemic myocardium. Such discordant findings between BMIPP and thallium were compared with those of PET using 18F-deoxyglucose (FDG) and 11C-acetate to assess metabolic alterations in such segment.
METHODS: Sixteen patients with coronary artery disease underwent both BMIPP SPECT and PET. Relative FDG uptake (% FDG uptake) and the clearance rate constant (% Kmono) of 11C-acetate from the myocardium were calculated as markers of glucose and oxidative metabolism, respectively.
RESULTS: Relative FDG uptake of the myocardial segments with reduced BMIPP uptake and normal thallium uptake (discordant segments) was similar (85.3 +/- 10.3) to that of the normal segments (86.5 +/- 11.7) but higher than that of segments with reduced uptake of both BMIPP and thallium (67.5 +/- 19.9). Similarly, the discordant segments showed a higher % Kmono value (77.8 +/- 13.1 versus 70.0 +/- 19.1) and FDG-to-perfusion ratio (1.15 +/- 0.08 versus 1.01 +/- 0.22) than in the concordantly reduced segments.
CONCLUSION: BMIPP uptake appears to provide metabolic information independent of thallium uptake. Combined imaging of BMIPP and thallium may potentially identify ischemic but viable myocardium.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7472584

Source DB:  PubMed          Journal:  J Nucl Med        ISSN: 0161-5505            Impact factor:   10.057


  25 in total

Review 1.  Future aspects of BMIPP.

Authors:  N Tamaki; K Morita; E Tsukamoto; Y Kawai
Journal:  Int J Card Imaging       Date:  1999-02

Review 2.  BMIPP in angina pectoris.

Authors:  S Nishimura; Y Ohta
Journal:  Int J Card Imaging       Date:  1999-02

3.  BMIPP compared with PET metabolism.

Authors:  E Tadamura; N Tamaki; T Kudoh; N Hattori; J Konishi
Journal:  Int J Card Imaging       Date:  1999-02

4.  Proceedings of the 4th Invitational Wintergreen Conference. Wintergreen, Virginia, USA. July 12-14, 1998. Abstracts.

Authors: 
Journal:  J Nucl Cardiol       Date:  1999 Jan-Feb       Impact factor: 5.952

Review 5.  The Japanese experience with metabolic imaging in the clinical setting.

Authors:  Nagara Tamaki; Koichi Morita; Yuko Kawai
Journal:  J Nucl Cardiol       Date:  2007 May-Jun       Impact factor: 5.952

6.  Prediction of functional recovery in acute myocardial infarction: comparison between sestamibi reverse redistribution and sestamibi/BMIPP mismatch.

Authors:  S Fujiwara; Y Takeishi; H Atsumi; M Yamaki; N Takahashi; M Yamaoka; T Tojo; H Tomoike
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

Review 7.  Cardiac BMIPP imaging in acute myocardial infarction.

Authors:  T Nakata; A Hashimoto; M Eguchi
Journal:  Int J Card Imaging       Date:  1999-02

Review 8.  BMIPP imaging to assess functional outcome in patients with acute and chronic left ventricular dysfunction.

Authors:  P R Franken; A S Hambÿe; F W De Geeter
Journal:  Int J Card Imaging       Date:  1999-02

Review 9.  Metabolic imaging using SPECT.

Authors:  Junichi Taki; Ichiro Matsunari
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

10.  Clinical utility of myocardial fatty acid imaging in patients with end-stage renal disease.

Authors:  Masato Nishimura; Toshihiko Ono
Journal:  J Nucl Cardiol       Date:  2008-09-16       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.